Valuation: Emblem Corp

Market Cap 248M 217M 204M 186M 348M 23.83B 349M 2.45B 945M 12.11B 933M 912M 38.98B P/E 2017
-16.3x
P/E 2018 -4.48x
Enterprise Value 219M 191M 181M 164M 307M 21.04B 308M 2.16B 835M 10.7B 824M 805M 34.42B EV / Sales 2017
72,352,077x
EV / Sales 2018 10,915,686x
Free-Float
98.36%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - 01/12/2017
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - 06/12/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+1.62% - - 0
-0.66%+1.29%-12.71%-5.50% 13.59B
0.00%-0.77%-33.26%-56.76% 4.75B
-0.68%-1.27%-5.37%-7.25% 4.31B
+0.53%+0.07%-7.65%-34.57% 3.79B
+0.16%+1.57%-1.06%-4.29% 3.46B
+1.38%-0.06%-21.64%+0.76% 3.44B
-0.57%-1.14%-11.32%-0.50% 3.09B
-0.62%+0.48%-22.17%-18.55% 2.25B
+0.52%+0.16%-27.89%-23.13% 1.64B
Average +0.17%-0.59%-15.90%-16.64% 4.03B
Weighted average by Cap. -0.17%-0.59%-14.67%-14.88%

Financials

2017 2018
Net sales 2.69 2.35 2.22 2.01 3.77 258.5 3.79 26.57 10.25 131.43 10.12 9.9 422.88 8.22 7.17 6.77 6.15 11.52 789.04 11.57 81.1 31.3 401.16 30.89 30.2 1.29K
Net income -12.1M -10.55M -9.96M -9.05M -16.95M -1.16B -17.02M -119M -46.06M -590M -45.46M -44.45M -1.9B -24.26M -21.15M -19.97M -18.14M -33.98M -2.33B -34.13M -239M -92.33M -1.18B -91.13M -89.11M -3.81B
Net Debt -21.51M -18.76M -17.71M -16.08M -30.14M -2.06B -30.26M -212M -81.87M -1.05B -80.81M -79.02M -3.38B -29.05M -25.33M -23.92M -21.72M -40.7M -2.79B -40.87M -287M -111M -1.42B -109M -107M -4.56B
Logo Emblem Corp
Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Company’s assets are located in Canada.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!